DD120303A1 - - Google Patents

Info

Publication number
DD120303A1
DD120303A1 DD18605875A DD18605875A DD120303A1 DD 120303 A1 DD120303 A1 DD 120303A1 DD 18605875 A DD18605875 A DD 18605875A DD 18605875 A DD18605875 A DD 18605875A DD 120303 A1 DD120303 A1 DD 120303A1
Authority
DD
German Democratic Republic
Application number
DD18605875A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to DD18605875A priority Critical patent/DD120303A1/xx
Publication of DD120303A1 publication Critical patent/DD120303A1/xx

Links

DD18605875A 1975-05-15 1975-05-15 DD120303A1 (https=)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DD18605875A DD120303A1 (https=) 1975-05-15 1975-05-15

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DD18605875A DD120303A1 (https=) 1975-05-15 1975-05-15

Publications (1)

Publication Number Publication Date
DD120303A1 true DD120303A1 (https=) 1976-06-05

Family

ID=5500313

Family Applications (1)

Application Number Title Priority Date Filing Date
DD18605875A DD120303A1 (https=) 1975-05-15 1975-05-15

Country Status (1)

Country Link
DD (1) DD120303A1 (https=)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023078386A1 (zh) 2021-11-05 2023-05-11 正大天晴药业集团股份有限公司 抗cldn18.2抗体及其用途
WO2023104080A1 (zh) 2021-12-07 2023-06-15 正大天晴药业集团股份有限公司 抗trop-2抗体或其抗原结合片段
WO2023143444A1 (zh) 2022-01-28 2023-08-03 上海君实生物医药科技股份有限公司 抗dkk1抗体、其药物组合物及用途
WO2024061334A1 (zh) 2022-09-23 2024-03-28 天辰生物医药(苏州)有限公司 FcεRI结合蛋白
WO2024240171A1 (zh) 2023-05-22 2024-11-28 上海君实生物医药科技股份有限公司 抗pd-1-抗vegf的双特异性抗体、其药物组合物及其用途
WO2025185773A1 (zh) 2024-03-05 2025-09-12 帆礼生物技术(武汉)有限公司 靶向tl1a的抗体及其应用

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023078386A1 (zh) 2021-11-05 2023-05-11 正大天晴药业集团股份有限公司 抗cldn18.2抗体及其用途
WO2023104080A1 (zh) 2021-12-07 2023-06-15 正大天晴药业集团股份有限公司 抗trop-2抗体或其抗原结合片段
WO2023143444A1 (zh) 2022-01-28 2023-08-03 上海君实生物医药科技股份有限公司 抗dkk1抗体、其药物组合物及用途
WO2024061334A1 (zh) 2022-09-23 2024-03-28 天辰生物医药(苏州)有限公司 FcεRI结合蛋白
WO2024240171A1 (zh) 2023-05-22 2024-11-28 上海君实生物医药科技股份有限公司 抗pd-1-抗vegf的双特异性抗体、其药物组合物及其用途
WO2025185773A1 (zh) 2024-03-05 2025-09-12 帆礼生物技术(武汉)有限公司 靶向tl1a的抗体及其应用

Similar Documents

Publication Publication Date Title
JPS5438020B2 (https=)
JPS5340614B2 (https=)
CH588071A5 (https=)
BG22103A1 (https=)
BG22191A1 (https=)
AU480907A (https=)
BG22941A1 (https=)
CH586956A5 (https=)
CH589129A5 (https=)
CH590459A5 (https=)
CH592213A5 (https=)
CH594131A5 (https=)
CH594455A5 (https=)
CH594560A5 (https=)
CH594811A5 (https=)
CH595479A5 (https=)
CH596617A5 (https=)
CH596999A5 (https=)
CH597693A5 (https=)
CH598003A5 (https=)
CH598005A5 (https=)
CH598272A5 (https=)
CH598404B5 (https=)
CH599253A5 (https=)
CH599868A5 (https=)